Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Voyager Names Steven Hyman To Board

This article was originally published in Scrip

Executive Summary

Voyager Therapeutics, Inc., a gene therapy company focusing on the CNS, has appointed Steven Hyman to its board of directors. With over 20 years of scientific leadership experience, Hyman has been president of the Society for Neuroscience and since 2012; he has been director of the Stanley Centre for Psychiatric Research at the Broad Institute of Harvard and MIT. Previously Hyman was the director of the US National Institute of Mental Health and was also the founding president of the International Neuroethics Society.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC029829

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel